Skip to main content
Watch Insiders
TLSIHealthcare

TriSalus Life Sciences Inc (TLSI) Insider Trading

In the last 90 days, 3 TriSalus Life Sciences Inc (TLSI) insiders reported no open-market purchases and 3 sales totaling $4,113. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 5, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 5, 2026Bryan F. CoxChief of ResearchSale296$4.39$1,299
Oct 5, 2026Richard MarshakChief Commercial OfficerSale325$4.39$1,427
Oct 5, 2026Jennifer StevensChief Regulatory OfficerSale316$4.39$1,387
May 15, 2026Richard MarshakChief Commercial OfficerSale543$2.67$1,450
May 15, 2026Mats WahlstromCorporate insiderOpen Market Purchase60,000$2.53$151,800
May 15, 2026Michael P StanskyCorporate insiderOpen Market Purchase610,000$2.50$1,525,000
May 15, 2026Mary T SzelaCEO and PresidentOpen Market Purchase39,682$2.59$102,776
May 15, 2026David PatienceChief Financial OfficerOpen Market Purchase7,100$2.43$17,253
May 15, 2026Gary B. GordonCorporate insiderOpen Market Purchase10,000$2.46$24,600

Common questions

TLSI insider trading FAQ

Are TLSI insiders buying or selling?
Over the last 90 days, TLSI insiders were net sellers, reporting $0.00 of open-market purchases and $4,113 of sales.
When was the last TLSI insider purchase?
No open-market insider purchase of TriSalus Life Sciences Inc stock was reported in the last 90 days.
Where does TLSI insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that TriSalus Life Sciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.